These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 37956916

  • 21. A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes.
    Khan FM, Gondil VS, Li C, Jiang M, Li J, Yu J, Wei H, Yang H.
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [Abstract] [Full Text] [Related]

  • 22. Yeast Surface Display System for Facilitated Production and Application of Phage Endolysin.
    Chun J, Bai J, Ryu S.
    ACS Synth Biol; 2020 Mar 20; 9(3):508-516. PubMed ID: 32119773
    [Abstract] [Full Text] [Related]

  • 23. Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria.
    Bai J, Yang E, Chang PS, Ryu S.
    Enzyme Microb Technol; 2019 Sep 20; 128():40-48. PubMed ID: 31186109
    [Abstract] [Full Text] [Related]

  • 24. Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria.
    Zampara A, Sørensen MCH, Grimon D, Antenucci F, Vitt AR, Bortolaia V, Briers Y, Brøndsted L.
    Sci Rep; 2020 Jul 21; 10(1):12087. PubMed ID: 32694655
    [Abstract] [Full Text] [Related]

  • 25. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kim S, Lee DW, Jin JS, Kim J.
    J Glob Antimicrob Resist; 2020 Sep 21; 22():32-39. PubMed ID: 32006750
    [Abstract] [Full Text] [Related]

  • 26. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S, Gu J, Lv M, Guo Z, Yan G, Yu L, Du C, Feng X, Han W, Sun C, Lei L.
    J Microbiol; 2017 May 21; 55(5):403-408. PubMed ID: 28124780
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N-Acetylmuramidase Activity.
    Rodríguez-Rubio L, Gerstmans H, Thorpe S, Mesnage S, Lavigne R, Briers Y.
    Appl Environ Microbiol; 2016 Aug 15; 82(16):4975-81. PubMed ID: 27287318
    [Abstract] [Full Text] [Related]

  • 29. Lysis of cells of diverse bacteria by l,d-peptidases of Escherichia coli bacteriophages RB43, RB49 and T5.
    Shadrin VS, Machulin AV, Dorofeeva LV, Chernyshov SV, Mikoulinskaia GV.
    J Appl Microbiol; 2021 Jun 15; 130(6):1902-1912. PubMed ID: 33107183
    [Abstract] [Full Text] [Related]

  • 30. Characterization of five novel endolysins from Gram-negative infecting bacteriophages.
    Walmagh M, Boczkowska B, Grymonprez B, Briers Y, Drulis-Kawa Z, Lavigne R.
    Appl Microbiol Biotechnol; 2013 May 15; 97(10):4369-75. PubMed ID: 22832988
    [Abstract] [Full Text] [Related]

  • 31. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84: defining a new endolysin catalytic subfamily.
    Love MJ, Coombes D, Ismail S, Billington C, Dobson RCJ.
    Biochem J; 2022 Jan 28; 479(2):207-223. PubMed ID: 34935873
    [Abstract] [Full Text] [Related]

  • 32. Effect of different cloning strategies in pET-28a on solubility and functionality of a staphylococcal phage endolysin.
    Tham HY, Song AA, Yusoff K, Tan GH.
    Biotechniques; 2020 Sep 28; 69(3):161-170. PubMed ID: 32787565
    [Abstract] [Full Text] [Related]

  • 33. Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin.
    Lim J, Jang J, Myung H, Song M.
    J Microbiol; 2022 Aug 28; 60(8):859-866. PubMed ID: 35614377
    [Abstract] [Full Text] [Related]

  • 34. In Vitro Study of Bacteriophage AB3 Endolysin LysAB3 Activity Against Acinetobacter baumannii Biofilm and Biofilm-Bound A. baumannii.
    Zhang J, Xu LL, Gan D, Zhang X.
    Clin Lab; 2018 Jun 01; 64(6):1021-1030. PubMed ID: 29945306
    [Abstract] [Full Text] [Related]

  • 35. Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin.
    Mayer MJ, Narbad A, Gasson MJ.
    J Bacteriol; 2008 Oct 01; 190(20):6734-40. PubMed ID: 18708505
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A novel phage-encoded endolysin EN534-C active against clinical strain Streptococcus agalactiae GBS.
    Bocanova L, Psenko M, Barák I, Halgasova N, Drahovska H, Bukovska G.
    J Biotechnol; 2022 Nov 20; 359():48-58. PubMed ID: 36179792
    [Abstract] [Full Text] [Related]

  • 39. A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability.
    Swift SM, Seal BS, Garrish JK, Oakley BB, Hiett K, Yeh HY, Woolsey R, Schegg KM, Line JE, Donovan DM.
    Viruses; 2015 Jun 12; 7(6):3019-34. PubMed ID: 26075507
    [Abstract] [Full Text] [Related]

  • 40. Cloning, Characterization, and Antibacterial Properties of Endolysin LysE Against Planktonic Cells and Biofilms of Aeromonas hydrophila.
    Baliga P, Goolappa PT, Shekar M, Kallappa GS.
    Probiotics Antimicrob Proteins; 2023 Jun 12; 15(3):646-654. PubMed ID: 34993932
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.